首页> 外文期刊>The pharmaceutical journal >New pseudoephedrine sales restrictions confirmed
【24h】

New pseudoephedrine sales restrictions confirmed

机译:确定了新的伪麻黄碱销售限制

获取原文
获取原文并翻译 | 示例
           

摘要

Tightened restrictions on counter sales of products that contain pseudoephedrine or ephedrine have been confirmed by the Medicines and Healthcare products Regulatory Agency.From 1 April,all packs of products that contain more than 720mg of pseudoephedrine or 180mg of ephedrine will be available only on prescription.The change is being made because of reports that over-the-counter medicines containing these ingredients are being used as source materials for the illicit manufacture of methylamphetamine.This is now believed to have happened on four occasions in the UK.
机译:药品和医疗保健产品监管局已确认对包含伪麻黄碱或麻黄碱的产品的加价销售实行严格限制。从4月1日起,所有包含720mg伪麻黄碱或180mg麻黄碱的产品包装都只能通过处方获得。之所以做出这一改变,是因为有报道称,含有这些成分的非处方药被用作非法制造甲基苯丙胺的原料。目前,据信在英国已经发生了四次。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号